|
[Subscribe
to SPIN]
Senator Harkin and Representative
Kennedy Welcome New Institute Directors
On May 22, the new Directors of the National Institute of
Mental Health (NIMH), the National Institute on Alcohol Abuse and
Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA)
received an official welcome on Capitol Hill from Members of Congress and
various constituent organizations. It might seem more appropriate to use
the term “relatively new”, but although Drs. Insel (NIMH) and Li (NIAAA)
were appointed in September 2002, they required time to transition from
established research careers and so really made their debuts at the
winter/spring round of NIH Advisory Council meetings. Dr. Volkow (NIDA),
the most recent appointee, really is new having assumed her position
full-time only in mid-April.
The reception was organized by APA Science Policy staff
and was co-sponsored by seventeen organizations which collectively
represent hundreds of thousands of scientists, healthcare providers and
patient advocates, and was meant to raise the profile of the new Institute
Directors with Members of Congress and their staff. With a view of the
Capitol in the background, 150 guests enjoyed good food and conversation
before hearing welcoming remarks from APA CEO Norman Anderson.
Senator Tom Harkin (D-IA), Ranking Member on the Senate
Appropriations Subcommittee that has jurisdiction over NIH funding, shared
his thoughts on the important work this new triumvirate would oversee. The
importance of translational research is a common theme heard on the Hill
these days as Congressional champions struggle to find additional funds
for NIH and Senator Harkin used this opportunity to reiterate the need to
take research from the bench to the bedside. Even though many SPIN readers
may know of Senator Harkin’s leadership, [along with that of the
Subcommittee Chairman, Arlen Specter (R-PA)] to double the NIH budget over
the past five years, some may not know that Senators Harkin and Specter
(R-PA) have introduced legislation to triple the NIH budget (proposing to
increase it to 41 billion by 2008). While that may be an uphill battle
given new estimates of the federal deficit and changing budgetary
priorities, even as a symbolic gesture, such legislation sets an important
tone in demonstrating support for research.Congressman Patrick Kennedy,
(D-RI), who serves on the corresponding appropriations subcommittee in the
House of Representatives, was also on hand to make remarks. Congressman
Kennedy, son of Senator Ted Kennedy (D-MA), provided a moving account of
how substance abuse and mental health issues had personally affected so
many members of his extended family. It is in part his willingness to
expose these vulnerabilities that have given him so much credibility in
his leadership of mental health parity legislation in the House. And like
Senator Harkin, Kennedy noted the critical need for research to inform
practice in the provision of services to the patient community.
The event was also meant for each of the new Directors to
provide some sense of their vision for their respective Institutes. As a
preface to that, Dr. Anderson introduced Raynard Kington, the new Deputy
Director of NIH, who had gone through his own set of recent transitions.
It did seem like a small world as Dr. Anderson, the first Director of the
NIH Office of Behavioral and Social Sciences Research (OBSSR), reviewed
Dr. Kington’s ascendance from Director of OBSSR to Acting Director of
NIAAA to his current position as second in command of NIH.
Dr. Kington then took a few moments to provide some
biographical context for each of the new Directors, who then in turn,
described what they each planned to do in managing the institutes under
their charge. At least one common theme emerged and it was clear to those
of us assembled that all three Directors understand the challenges facing
the research community and want to facilitate the entry of new scientists
into mental health and substance abuse research careers.
View
photographs of the reception
[back to top]
Sparking Congressional Interest in NICHD Research
On June 2, the Friends of NICHD, co-chaired by APA's Karen
Studwell, co-sponsored a congressional briefing with the Ad Hoc Group for
Medical Research Funding featuring Duane Alexander, MD, Director of NICHD.
The purpose of the briefing was to educate policymakers and their staff
about the congressionally authorized National Children's Study (NCS) and
the impact it will have on NICHD's budget. The proposed study plans to
enroll a cohort of 100,000 children to determine the physical, social, and
behavioral environmental influences on child health and development. Dr.
Alexander explained that in order for the study to go forward, NICHD would
require significantly more resources in FY2005 and beyond to fund the
study and also preserve its other research programs. Given the current
budget outlook for FY 2004 and FY2005 funding, it is unclear whether there
will be adequate funds to begin enrollment.
APA Psychologists Testify at Tobacco
Control Hearing
On June 3rd, three APA psychologists testified before the
House Government Reform Committee on "Reduced Exposure/Reduced Risk
Tobacco Products: An Examination of the Potential Public Health Impact and
Regulatory Challenges". Jack Henningfield, Dorothy Hatsukami and Lynn
Kozlowski were all pitted against tobacco industry leaders, Michael
Szymanczyck (Phillip Morris) and Richard Verheij (U.S. Smokeless Tobacco
Co.) and all were asked to address four key questions:
- A number of non-tobacco products have entered the market in recent
years designed to provide sources of nicotine other than cigarettes.
These include water, gum, nasal sprays and patches. In your opinion,
would products such as these be feasible for long-term use for those
unable to quit smoking altogether?
- In what ways does the current regulatory structure hinder the
development of these nicotine products?
- Should the federal government be encouraging greater use of these
nicotine products? How could it do so?
- In your opinion, do reduced risk tobacco products have a place in
the country's tobacco control efforts, or should efforts be restricted
to medicinal nicotine or non-tobacco products?
Read
the testimony by Drs. Henningfield, Hatsukami and Kozlowski
Read
Chairman Tom Davis' (R-VA) opening statement
Science Policy staff are always pleased to serve as a
sounding board and otherwise help psychologists prepare testimony for
Congressional hearings. We are pleased to note that Drs. Hatukami and
Kozlowski are both alumni of an invitational Science Advocacy Training
Workshop held in the fall of 1997 which APA devoted to tobacco control
policy issues.
[back to top]
AHRQ DIRECTOR CAROLYN CLANCY HONORED BY FRIENDS OF
AHRQ
On June 4, APA co-sponsored a reception honoring the
appointment of Carolyn Clancy, M.D. as Director of the Agency for
Healthcare Research and Quality (AHRQ). As a member of the Friends of AHRQ,
APA has been supportive of dramatic funding increases for the agency,
which among other initiatives has taken leadership on research to reduce
human error and enhance patient safety in healthcare settings. Immediately
preceding the reception, Dr. Clancy participated in a Congressional
briefing to review the AHRQ patient safety research portfolio. During that
briefing, Lucian Leape, M.D., the physician most often associated with
leading the patient safety movement, lauded the role of human factors
research and cognitive psychology in changing the way healthcare
professionals viewed medical error and specifically cited APA Fellow David
Woods' seminal contributions to the field.
More
information on AHRQ's medical error research portfolio
Capitol Hill Reception Highlighting NSF-Funded
Researchers Includes Two Psychologists
On June 17, both APA and the Federation of Behavioral,
Psychological, and Cognitive Sciences (of which APA is a member) showcased
psychological research funded by the National Science Foundation (NSF) at
a Capitol Hill Exhibit and Reception. The event, sponsored by the
Coalition for National Science Funding, drew over 270 attendees, including
eight Members of Congress: Reps. Frank Ballance, Jr. (D-NC), Lois Capps
(D-CA), Howard Coble (R-NC), Vernon Ehlers (R-MI), Dale Kildee (D-MI), Jim
Kolbe (R-AZ), Mike McIntyre (D-NC), and David Price (D-NC). Also in
attendance were Dr. Rita Colwell, Director of NSF, and Dr. Kathie Olsen,
Associate Director for Science at the White House Office of Science and
Technology Policy. APA's exhibitor, Dr. Linda A. Jackson from Michigan
State University, presented results from her "HomeNetToo"
project, which examines the effects of home Internet use on low-income
families. The Federation highlighted research by APA member Dr. Barbara
Landau (the Johns Hopkins University) and her colleague Dr. Jim Hoffman
(University of Delaware).
View
photographs from the reception
[back to top]
APA Participates in Annual DoD Research Lobby Events
on Capitol Hill
Each year the Coalition for National Security Research (CNSR)
holds a Lobby Day, during which the science community heads to Capitol
Hill to advocate for the research programs sponsored by the Department of
Defense (DoD). This year the blitz lobbying events and visits were spread
over two days in early June. Over 170 members of Congress, their staff,
DoD personnel and scientists enjoyed an evening reception, and APA member
Gerald Krueger joined Science Policy staffer Heather Kelly at a breakfast
featuring Senator Pat Roberts (R-KS), Chairman of the Senate Select
Committee on Intelligence and member of the Senate Armed Services
Committee. Sen. Roberts spoke forcefully about the need for and his
commitment to a significant investment in science and technology
(including psychological research) within DoD. CNSR member organizations,
which include universities and science associations, made over 30 visits
to congressional offices, and continue to work with staff in those offices
as the defense appropriations bills start to move through committees in
the House and Senate.
Research Appropriations Process
Begins-Funding Increases Will Likely be Lower for Fiscal Year 2004
The National Institutes of Health would receive an
approximate 2.2% increase-- $27.66 billion-- under the Fiscal Year 2004
spending bill marked June 19 by the House Appropriations Subcommittee on
Labor, Health and Human Services, Education and Related Agencies (Labor/HHS).
The full House Appropriations Committee approved the bill on June 25 with
few changes.
The Labor/HHS Subcommittee was allocated $138.04 billion
for discretionary spending, an increase of $3.68 billion, or less than 3%,
over FY 2003 levels. The House Labor/HHS bill provides NIH a $682 million
increase (2.2%) from the agency's FY 2003 appropriation of $26.9 billion.
However, because of one-time costs in FY 2003, the House Appropriations
Committee leadership said that the actual increase is closer to 7% than
2.2%. It was unclear at press time how those additional funds would flow
to the budgets of NIH institutes. NIH spokespeople have said that a 2.2%
increase would allow an increase of just 0.2% in the number of new and
competing research grants.
The Senate Subcommittee on Labor/HHS, chaired by long-time
NIH supporter Arlen Specter (R-PA), also marked its version of the
legislation on June 25. The Senate bill includes a $1 billion increase for
NIH, a 3.3 percent increase. The full Senate Appropriations Committee,
chaired by Senator Ted Stevens (R-AK), approved the legislation on June
26. Senator Tom Harkin (D-IA) stated that members would seek to add more
funds to the bill through amendments once the bill is brought to the
Senate floor, which is expected in mid-July.
APA and its coalition partners have been lobbying this
spring for a 10% increase in NIH funding for FY 04, arguing that after
five years of 15% increases, it would be difficult for NIH to transition
smoothly with much less. In the past, the Labor/HHS bill has been the last
or one of the last of the thirteen appropriations bills to be enacted, but
this year it looks as if it will be one of the first.
[back to top]
OMB Efficiency Initiative Concerns NIH
Staff and Researchers
The efforts of the Bush Administration to increase
government efficiency and reduce the size of the federal workforce have
caused much confusion and anxiety in many federal departments, including
the National Institutes of Health. The main concern for organizations like
APA is the possible detrimental impact competitive sourcing may have on
grants management functions and scientific program/review positions, as it
is unclear how far the government will go in competitively bidding many of
the functions currently performed by government employees.
At issue is an executive rule implemented by the Office of
Management and Budget known as Circular A-76, which describes procedures
for determining which functions now being conducted by government
employees might be more efficiently or less expensively performed by
private contractors. All federal departments are implementing the circular
by reviewing the functions of their own workforces. The process has raised
concerns that the scientific functions of the government might be
compromised if scientific positions are outsourced, and if the scientific
agencies lose control over which scientists are hired for important
grants-related positions.
In June, NIH Director Elias Zerhouni, MD, addressing the
National Institute of Child Health and Human Development Advisory Council,
acknowledged that the process has caused some anxiety among the NIH staff
and scientific organizations. He reiterated that the initial process would
begin with a determination of which functions are inherently
"non-governmental" and should be reviewed. Those functions will
not automatically be outsourced, but will go through a competitive bidding
process. Dr. Zerhouni emphasized that NIH will also be competing in the
process, and will likely win most of those competitions given its
expertise and demonstrated efficiency. He reiterated that with NIH's
overall management costs at approximately four percent, it is one of the
government's most efficient agencies.
In FY 2003, a full generic competition is ongoing in
grants (including program management, review and administrative support),
real property (facilities) management, and "other
opportunities," a catch-all category that enables the review teams to
be flexible about their targets. In FY 2004, the targets are fire
prevention, functions that were scheduled for FY2003 but did not get
finished and, again, "other opportunities."
NIH management staff at an A-76 Town Meeting in March
assured a questioner that the health scientist administrator position is
not scheduled for competition. Health science administrators have
responsibility for scientific portfolios of grants and interact with
scientists. It is possible that after review, NIH may decide that some
more administrative grant management functions could be contracted out,
but that determination has not been made.
By FY 2004, NIH must review 25 percent of the more than
9,300 jobs that are not considered "inherently governmental" and
therefore could potentially be performed by outside contractors.
Functions, not individual employees, are the subject of A-76 review.
According to the NIH Record, functions are picked based on where NIH feels
it can best improve its mission. The steering committee looked at all
functions and ranked those with the greatest opportunities for
improvement.
APA Science Policy staff is monitoring the implementation
of Circular A-76 and several other issues that may detrimentally impact
the management of NIH. APA is currently working in collaboration with
other scientific organizations to communicate our concerns with NIH
Director Elias Zerhouni, Secretary of HHS Tommy Thompson, recently
nominated Office of Management and Budget Director Joshua Bolten and key
congressional offices.
More
information on the A-76 process from the NIH Web site
Senate Encourages Behavioral Research at NIH
Each year both the House and Senate Appropriations
Committees issue reports that accompany their versions of the coming
year's spending bills. The Public Policy Office works with those
committees to suggest language, or topics for language, on behavioral
research at various NIH institutes. Although the suggestions in the
reports do not carry the force of law, they are closely studied by
administrators at NIH and demonstrate the Committee's interest in and
support of various areas of research. For that reason we read through the
massive report as soon as we get it to see which of our suggestions made
it into print.
Here
is a sample of some APA-inspired language from Senate report
108-81, accompanying the bill to fund the US Departments of Labor, Health
and Human Services, Education and Related Agencies for Fiscal Year 2004.
[back to top]
Any questions?
If you have any questions regarding SPIN or specific
science policy issues, please feel free to contact any of APA’s Science
PPO staff.
Geoff
Mumford, Ph.D., Director of Science Policy
Pat
Kobor, Senior Science Policy Analyst
Heather
O'Beirne Kelly, Ph.D., Senior Legislative and Federal Affairs Officer
Karen
Studwell, J.D., Legislative and Federal Affairs Officer
|